Argenx Se logo

Argenx Se Share Price Today (NASDAQ: ARGX)

Argenx Se share price is 543.06 & ₹46,283.92 as on 14 May 2025, 2.30 'hrs' IST

$543.06

-17.84

(-3.18%)

Market is closed - opens 7 PM, 14 May 2025

View live Argenx Se share price in Dollar and Rupees. Guide to invest in Argenx Se stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Argenx Se, along with analyst recommendations, forecasts, and comprehensive financials.

Argenx Se share price movements

  • Today's Low: $540.00
    Today's High: $549.82

    Day's Volatility :1.79%

  • 52 Weeks Low: $352.77
    52 Weeks High: $678.21

    52 Weeks Volatility :47.99%

Argenx Se (ARGX) Returns

PeriodArgenx SeSector (Health Care)Index (Russel 2000)
3 Months
-13.89%
-7.1%
0.0%
6 Months
-6.75%
-7.4%
0.0%
1 Year
56.99%
-5.2%
0.0%
3 Years
80.93%
5.7%
-1.3%

Argenx Se (ARGX) Key Statistics

in dollars & INR

Previous Close
$560.9
Open
$549.75
Today's High
$549.82
Today's Low
$540.0
Market Capitalization
$33.6B
Today's Volume
$657.8K
52 Week High
$678.21
52 Week Low
$352.77
Revenue TTM
$2.6B
EBITDA
$191.0M
Earnings Per Share (EPS)
$16.38
PE Ratio
33.56
Profit Margin
40.26%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
17.36%

How to invest in Argenx Se Stock (ARGX) from India?

It is very easy for Indian residents to invest directly in Argenx Se from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Argenx Se stock in both Indian Rupees (INR) and US Dollars (USD). Search for Argenx Se or ARGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Argenx Se or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Argenx Se shares which would translate to 0.002 fractional shares of Argenx Se as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Argenx Se, in just a few clicks!

Returns in Argenx Se (ARGX) for Indian investors in Rupees

The Argenx Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Argenx Se investment value today

Current value as on today

₹1,53,157

Returns

₹53,157

(+53.16%)

Returns from Argenx Se Stock

₹51,068 (+51.07%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Argenx Se (ARGX)

169.23%

Period: Apr 13, 2025 to May 13, 2025. Change in 30 Days versus previous period

Investment in Argenx Se Shares from India has grown by 169.23% over the past 30 days, indicating increased transactional activity.

-35%

Period: Apr 13, 2025 to May 13, 2025. Change in 30 Days versus previous period

Search interest for Argenx Se Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Argenx Se

  • FMR Inc

    9.20%

  • T. Rowe Price Associates, Inc.

    9.04%

  • Artisan Partners Limited Partnership

    5.03%

  • HHG PLC

    3.79%

  • Capital World Investors

    2.93%

  • venBio Select Advisor LLC

    2.03%

Analyst Recommendation on Argenx Se

Rating
Trend

Buy

    72%Buy

    24%Hold

    4%Sell

Based on 25 Wall street analysts offering stock ratings for Argenx Se(by analysts ranked 0 to 5 stars)

Analyst Forecast on Argenx Se Stock (ARGX)

What analysts predicted

Upside of 38.8%

Target:

$753.75

Current:

$543.06

Insights on Argenx Se Stock (Ticker Symbol: ARGX)

  • Price Movement

    In the last 7 days, ARGX stock has moved down by -9.1%
  • Decreasing Revenue

    Argenx Se has experienced a decline in revenue over the past two quarters. The revenue decreased from $1.30 billion to $790.68 million, averaging a drop of 39.3% each quarter.
  • Decreasing Net Profit

    Argenx SE has seen a significant decline in its net profit over the last two quarters. The company's net profit dropped from $835.53 million to $169.46 million, representing an average decrease of 79.7% each quarter.
  • ARGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 79.9% return, outperforming this stock by 24.4%
  • ARGX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.2% return, outperforming this stock by 33.9%
  • Price to Sales

    Argenx SE has a very high Price-to-Sales Ratio of $318.6, meaning investors are willing to pay $318.6 for every $1 of sales the company generates. In comparison, Alnylam Pharmaceuticals is much lower at a Price-to-Sales Ratio of $14.8. This suggests that investors view Argenx SE as having strong growth potential compared to Alnylam Pharmaceuticals.

Argenx Se Technicals Summary

Sell

Neutral

Buy

Argenx Se is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Argenx Se (ARGX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Argenx Se logo
-7.83%
-6.75%
56.99%
80.93%
256.35%
Regeneron Pharmaceuticals, Inc. logo
0.72%
-28.49%
-41.58%
-12.19%
-0.27%
Vertex Pharmaceuticals Incorporated logo
-11.36%
-11.14%
2.54%
72.91%
52.24%
Alnylam Pharmaceuticals, Inc. logo
12.33%
1.89%
82.3%
115.9%
93.57%

About Argenx Se

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Organization
Argenx Se
Employees
1599
CEO
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Industry
Health Technology

Management People of Argenx Se

NameTitle
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Co-Founder, CEO & Executive Director
Mr. Karl Gubitz
Chief Financial Officer
Ms. Karen Massey
Chief Operating Officer
Dr. Peter Ulrichts
Chief Scientific Officer
Ms. Malini Moorthy
General Counsel
Mr. Arjen Lemmen M.Sc.
Vice President of Corporate Development & Strategy
Ms. Andria Wilk
Global Head of Quality
Dr. Luc Truyen
Chief Medical Officer
Mr. Filip Borgions
VP & Global Head of Technical Operations
Ms. Beth DelGiacco
VP and Global Head of Corporate Communications & Investor Relations

Important FAQs about investing in ARGX Stock from India :

Can Indians buy Argenx Se shares?

Yes, Indians can invest in the Argenx Se (ARGX) from India.

With INDmoney, you can buy Argenx Se at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Argenx Se at zero transaction cost.

How can I buy Argenx Se shares from India?

It is very easy to buy Argenx Se from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Argenx Se (ARGX) be purchased?

Yes, you can buy fractional shares of Argenx Se with INDmoney app.

What are the documents required to start investing in Argenx Se stocks?

To start investing in Argenx Se, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Argenx Se share price today?

Argenx Se share price today stands at $543.06, Open: $549.75 ; Previous Close: $560.90 ; High: $549.82 ; Low: $540.00 ; 52 Week High: $678.21 ; 52 Week Low: $352.77.

The stock opens at $549.75, after a previous close of $560.90. The stock reached a daily high of $549.82 and a low of $540.00, with a 52-week high of $678.21 and a 52-week low of $352.77.

What are today’s High and Low prices of Argenx Se Stock (ARGX)?

Today’s highest price of Argenx Se (ARGX) is $549.82.

Today’s lowest price of Argenx Se (ARGX) is $540.00.

What is the 52 Week High and Low Range of Argenx Se Stock (ARGX)?

  • 52 Week High

    $678.21

  • 52 Week Low

    $352.77

What are the historical returns of Argenx Se (ARGX)?

  • 1 Month Returns

    -7.83%

  • 3 Months Returns

    -6.75%

  • 1 Year Returns

    56.99%

  • 5 Years Returns

    256.35%

What is today's market capitalisation of Argenx Se?

Today's market capitalisation of Argenx Se ARGX is 33.6B

Who is the Chief Executive Officer (CEO) of Argenx Se ?

Mr. Timothy Van Hauwermeiren EMBA, M.Sc. is the current Chief Executive Officer (CEO) of Argenx Se.